{"schema_version":"alpha-profile-public-v1","slug":"sharon-shacham-ph-d-m-b-a","canonical_url":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a","as_of":"2026-09-22T00:18:04.710988+00:00","published_at":"2026-09-02T02:37:22.38891+00:00","last_reviewed_at":"2026-05-15T22:08:14.33+00:00","identity":{"display_name":"Sharon Shacham, Ph.D., M.B.A.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=sharon-shacham-ph-d-m-b-a","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=sharon-shacham-ph-d-m-b-a&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Shacham co-founded E44 Ventures in June 2022 and serves as Managing Director. She founded Karyopharm Therapeutics Inc. in 2008 and served in various leadership roles including Chief Scientific Officer and President. She led the scientific and clinical work that resulted in the discovery and regulatory approval of selinexor (Xpovio), a first-in-class XPO1 inhibitor."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Acrivon Therapeutics, Inc.","organizationId":"acrivon-therapeutics-inc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Sharon Shacham, Ph.D., M.B.A. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.321219+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Sharon Shacham, Ph.D., M.B.A. currently serves as Director at Acrivon Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.28358+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation"],"claim_text":"Sharon Shacham, Ph.D., M.B.A. serves on Compensation.","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.305996+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"E44 Ventures","claim_text":"Sharon Shacham, Ph.D., M.B.A. is linked to E44 Ventures as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.423833+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Managing Director","claim_text":"Sharon Shacham, Ph.D., M.B.A. is also listed as Managing Director.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.406555+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Sharon Shacham, Ph.D., M.B.A. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.352702+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Sharon Shacham, Ph.D., M.B.A. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:21.337424+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:21.205531+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:sharon-shacham-ph-d-m-b-a","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Acrivon Therapeutics, Inc.","organization_id":"acrivon-therapeutics-inc"},"claim_text":"Director at Acrivon Therapeutics, Inc. (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a#profile","url":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a","dateModified":"2026-05-15T22:08:14.33+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a#person","name":"Sharon Shacham, Ph.D., M.B.A.","url":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","tickerSymbol":"NASDAQ: ACRV"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/acrivon-therapeutics-inc","tickerSymbol":"NASDAQ: ACRV"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","name":"ACRV DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-15T22:08:14.33+00:00","observed_at":"2026-09-22T00:18:04.710988+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"sharon-shacham-ph-d-m-b-a","canonical_url":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a"},"publication":{"published_at":"2026-09-02T02:37:22.38891+00:00","last_reviewed_at":"2026-05-15T22:08:14.33+00:00","as_of":"2026-09-22T00:18:04.710988+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/sharon-shacham-ph-d-m-b-a","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/sharon-shacham-ph-d-m-b-a.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}